Table 3.
E-cadherin expression in colorectal cancer and para-cancer tissues with clinical features
| Clinical data | Case (n) | E-cadherin (2-ΔΔCt) (X̅ ± S) | P value |
|---|---|---|---|
| Gender | 0.514 | ||
| Male | 20 | 0.441 ± 0.093 | |
| Female | 17 | 0.415 ± 0.115 | |
| Age | 0.322 | ||
| < 60 | 10 | 0.356 ± 0.121 | |
| ≥ 60 | 27 | 0.427 ± 0.103 | |
| Tumor size | 0.274 | ||
| < 5 cm | 19 | 0.514 ± 0.133 | |
| ≥ 5 cm | 18 | 0.611 ± 0.104 | |
| Differentiation level | 0.0003 | ||
| Median to high | 32 | 0.452 ± 0.106 | |
| Low | 5 | 0.224 ± 0.119 | |
| Local invasion depth | 0.0001 | ||
| T1/T2 | 9 | 0.325 ± 0.042 | |
| T3/T4 | 28 | 0.198 ± 0.025 | |
| Dukes staging | 0.0002 | ||
| A/B | 22 | 0.304 ± 0.101 | |
| C/D | 15 | 0.218 ± 0.126 | |
| Vascular invasion | 0.0001 | ||
| No | 27 | 0.377 ± 0.089 | |
| Yes | 10 | 0.298 ± 0.073 | |
| Tumor location | 0.896 | ||
| Colon | 18 | 0.614 ± 0.119 | |
| Rectus | 19 | 0.599 ± 0.203 | |
| CEA (ng/ml) | 0.086 | ||
| < 6.50 | 15 | 0.622 ± 0.077 | |
| ≥ 6.50 | 22 | 0.583 ± 0.083 | |
| CA19-9 (U/ml) | 0.0004 | ||
| < 37.00 | 25 | 0.378 ± 0.110 | |
| ≥ 37.00 | 12 | 0.226 ± 0.088 |